Access cutting-edge breast cancer treatment through this clinical trial at a research site in Cerritos. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Cerritos at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this breast cancer clinical trial in Cerritos, CA
If you're searching for breast cancer treatment options in Cerritos, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cerritos research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.